KCT0005164招募中未知
A prospective study to evaluate the efficacy and safety of a new knife in endoscopic submucosal dissection for gastric neoplasm
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 0No Limit（—）
- 性别
- All
入选标准
- •1. 19 years old or older
- •2. Diagnosed as adenoma or early gastric cancer and meets the indications for endoscopic resection
- •3. Where he/she voluntarily signed a written informed consent form after hearing an explanation of the purpose, method, effect, etc. of the study
排除标准
- •1. Women of childbearing potential who are unable to use adequate contraception or are pregnant or lactating
- •2. Past history of gastrectomy
- •3. When endoscopic resection cannot be safely performed due to hemorrhagic disease or coagulation disorder
- •4. When the investigator determines that endoscopic resection is impossible
研究者
相似试验
招募中
不适用
A prospective study to evaluate the efficacy and safety of pregabalin for triweekly abraxane-induced peripheral neuralgiaBreast cancerJPRN-UMIN000006987Kinki University Faculty of Medicine30
已完成
2 期
Prospective study of evaluating the efficacy and safety of Radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastasescastration-resistant prostate cancer with bone metastasesJPRN-UMIN000023897ational Hospital Organization Saitama Hospital20
尚未招募
不适用
effect of alpha blockers in benign prostatic hyperplasiaCTRI/2021/04/033122DR I C VIGNESH RAJA
进行中（未招募）
2 期
A prospective study of investigating the efficacy of FOLFIRI plus Aflibercept as a 2nd line therapy after progression during FOLFOXIRI plus Bevacizumab in unrescetable / metastatic colorectal cancer (CRC) patients.Colorectal CancerJPRN-jRCTs071190003Oki Eiji35
招募中
不适用
A prospective study to assess the efficacy and safety of the BlueWind RENOVA iStim* System for the treatment of patients diagnosed with overactive bladder (OASIS - OverActive bladder StImulation System study)Overactive bladderfrequent need to urinate10004994NL-OMON55598BlueWind Medical Ltd.25